Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

The last year was a momentous one for RSV research with more than one vaccine and a new treatment for infants being approved to target RSV disease. In this month’s cover story, we track how these vaccines and treatments will now get to those who need them the most by looking at the initial rollout in Spain, and what lessons that may have for the rest of the world. 

This month’s issue also features a high-profile exclusive interview with the director of Biomedical Advanced Research and Development Authority (BARDA)’s medical countermeasures programs outlining the agency’s focus areas for the future. 

Don’t miss coverage on the pricing implications of the world’s most expensive therapy, the latest fad involving molecular glues, and much more.

Manasi Vaidya, editor